药易购(300937) - 2024 Q1 - 季度财报

Revenue and Profit - Revenue for the first quarter of 2024 was RMB 1,237,408,296.37, a 10.29% increase compared to the same period last year[5] - Total revenue for Q1 2024 reached 1,237,408,296.37 RMB, a 10.3% increase compared to 1,121,966,149.54 RMB in the same period last year[18] - Net profit attributable to shareholders of the listed company was RMB 9,225,531.31, a 70.84% decrease year-over-year[5] - Net profit attributable to the parent company was 9,225,531.31 RMB, a significant decline from 31,632,639.16 RMB in Q1 2023[20] - Operating profit declined sharply to 6,447,362.40 RMB, an 81.3% decrease from 34,406,195.40 RMB in Q1 2023[20] - Basic earnings per share decreased to 0.0964 RMB, down 70.8% from 0.3300 RMB in the same period last year[20] Cash Flow - Net cash flow from operating activities improved by 38.50% to RMB -72,039,212.99 compared to the same period last year[5] - Net cash flow from operating activities was -72.04 million yuan, an improvement from the previous period's -117.14 million yuan[22] - Net cash flow from investing activities was -9.34 million yuan, compared to -7.40 million yuan in the previous period[22] - Net cash flow from financing activities was 82.75 million yuan, a significant improvement from the previous period's -106.43 million yuan[22] - The net increase in cash and cash equivalents was 1.37 million yuan, compared to a decrease of 230.98 million yuan in the previous period[23] - The ending balance of cash and cash equivalents was 192.86 million yuan, up from 103.62 million yuan in the previous period[23] Assets and Liabilities - Total assets increased by 14.90% to RMB 1,938,430,288.21 compared to the end of the previous year[5] - Total assets increased to 1,938,430,288.21 RMB, up 14.9% from 1,687,065,227.46 RMB at the end of the previous quarter[17] - Total liabilities grew by 29.4% to 1,075,166,045.38 RMB compared to 831,023,467.80 RMB at the end of the previous quarter[17] - Total equity increased slightly to 863,264,242.83 RMB, up 0.8% from 856,041,759.66 RMB at the end of the previous quarter[18] - The company's monetary funds at the end of the period amounted to 378,472,730.05 yuan, an increase from 374,864,119.57 yuan at the beginning of the period[16] - Total current assets increased to 1,625,252,317.69 yuan from 1,376,442,625.78 yuan at the beginning of the period[16] - Long-term equity investments increased to 16,371,914.19 yuan from 10,829,001.79 yuan at the beginning of the period[16] - Fixed assets slightly decreased to 141,531,353.32 yuan from 142,203,630.71 yuan at the beginning of the period[16] - Construction in progress increased to 6,063,976.47 yuan from 2,205,713.34 yuan at the beginning of the period[16] - Intangible assets decreased to 45,423,955.95 yuan from 46,432,202.40 yuan at the beginning of the period[16] Accounts Receivable and Payable - Accounts receivable increased by 271.89% to RMB 457,924,110.30 due to sales growth and extended payment terms[9] - Accounts receivable increased significantly to 457,924,110.30 yuan from 123,134,181.47 yuan at the beginning of the period[16] - Accounts payable increased significantly by 68.7% to 356,872,520.01 RMB from 211,493,306.55 RMB in the previous quarter[17] Borrowings and Financial Expenses - Short-term borrowings increased by 27.43% to RMB 408,706,533.89 due to new working capital loans[9] - Short-term borrowings rose by 27.4% to 408,706,533.89 RMB compared to 320,738,176.85 RMB in the previous quarter[17] - Financial expenses surged by 86.50% to RMB 2,082,577.74 mainly due to increased interest expenses[9] - The company received 176 million yuan from borrowings, compared to 0 in the previous period[23] - The company repaid 88 million yuan of debt, a decrease from the previous period's 105.42 million yuan[23] Sales and R&D Expenses - Sales expenses increased by 22.78% to RMB 53,858,024.16 due to expanded sales scale and increased promotion costs[9] - R&D expenses increased slightly to 4,797,456.92 RMB, up 2.7% from 4,671,770.57 RMB in Q1 2023[18] - Sales of goods and services received cash of 977.65 million yuan, an increase of 26.25% compared to the previous period's 774.39 million yuan[22] Investment Activities - Investment activities cash outflow increased by 26.25% to RMB -9,344,760.89 due to new investments[10] - Net cash flow from investing activities was -9.34 million yuan, compared to -7.40 million yuan in the previous period[22] Shareholders and Ownership - The total number of ordinary shareholders at the end of the reporting period is 14,126[11] - Li Yanfei, the largest shareholder, holds 36.97% of the shares, totaling 35,370,000 shares[11] Inventory - Inventory decreased to 516,841,959.20 yuan from 561,237,355.76 yuan at the beginning of the period[16] Audit Status - The company's first quarter report was not audited[24]